| |
| |
|
| Insider
Information: |
Zeldis Jerome B |
| Relationship: |
Executive VP of Resear... |
| City: |
Scottsdale |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
971,920 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,554,066 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
971,920 |
|
|
| Total
Value |
$2,554,066 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -40.7%
|
-29.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alliqua BioMedical Inc |
ALQA |
Director |
2017-06-23 |
786,750 |
2013-02-22 |
0 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
Director |
2021-05-14 |
22,917 |
2013-06-20 |
0 |
Premium* |
|
|
Biosig Technologies, Inc. |
BSGM |
Director |
2020-05-28 |
107,944 |
|
0 |
Premium* |
|
|
Sorrento Therapeutics Inc |
SRNE |
See Remarks |
2017-02-03 |
10,000 |
2017-02-03 |
0 |
Premium* |
|
|
Metastat Inc |
MTST |
|
2017-04-04 |
20,000 |
2017-04-04 |
0 |
Premium* |
|
|
Beyond Air Ord Shs |
XAIR |
Director |
2017-03-14 |
3,927 |
|
0 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
14,500 |
2020-01-29 |
0 |
Premium* |
|
|
Neximmune, Inc. |
NEXI |
Executive VP of Resear... |
2021-02-17 |
5,882 |
2021-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
14,500 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
10,500 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
3,200 |
6,500 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2021-05-14 |
4 |
S |
$0.90 |
$2,701 |
D/D |
(3,000) |
22,917 |
0 |
% |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2021-05-14 |
4 |
B |
$0.89 |
$2,664 |
D/D |
3,000 |
25,917 |
2.31 |
% |
|
| NEXI |
Neximmune, Inc. |
Executive VP of Research & Dev |
• – – |
2021-02-17 |
4 |
B |
$17.00 |
$99,994 |
D/D |
5,882 |
5,882 |
2.74 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
3,300 |
0 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2020-05-28 |
4 |
B |
$10.49 |
$10,489 |
D/D |
1,000 |
107,944 |
2.39 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,650 |
1,650 |
0 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2019-11-19 |
4 |
B |
$0.93 |
$1,850 |
D/D |
2,000 |
22,917 |
2.31 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2019-09-19 |
4 |
B |
$0.94 |
$3,740 |
D/D |
4,000 |
20,917 |
2.31 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2019-05-22 |
4 |
OE |
$3.40 |
$75,514 |
D/D |
21,097 |
106,944 |
0 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2019-05-21 |
4 |
A |
$7.44 |
$28,302 |
D/D |
3,804 |
85,847 |
0 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2019-05-21 |
4 |
OE |
$3.75 |
$50,003 |
D/D |
13,334 |
82,043 |
0 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2019-05-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
68,709 |
|
- |
|
| ALQA |
Alliqua BioMedical Inc |
Director |
– • – |
2017-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
786,750 |
0 |
- |
|
| MTST |
Metastat Inc |
|
– • – |
2017-04-04 |
4 |
B |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0.01 |
- |
|
| XAIR |
Beyond Air Ord Shs |
Director |
– • – |
2017-03-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,927 |
|
- |
|
| ALQA |
Alliqua BioMedical Inc |
Director |
– • – |
2017-02-27 |
4 |
B |
$0.50 |
$200,000 |
D/D |
400,000 |
686,750 |
2.39 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
See Remarks |
• – – |
2017-02-03 |
4 |
B |
$5.15 |
$51,500 |
D/D |
10,000 |
10,000 |
2.74 |
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2015-12-23 |
4 |
B |
$1.27 |
$3,175 |
D/D |
2,500 |
69,166 |
2.31 |
- |
|
| ALQA |
Alliqua BioMedical Inc |
Director |
– • – |
2015-11-06 |
4 |
B |
$2.91 |
$40,740 |
D/D |
14,000 |
286,750 |
2.39 |
- |
|
| BSGM |
Biosig Technologies, Inc. |
Director |
– • – |
2015-07-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
137,245 |
|
- |
|
| SNGX |
Soligenix Inc Common |
Director |
– • – |
2015-04-09 |
4 |
OE |
$0.61 |
$10,893 |
D/D |
17,857 |
66,666 |
0 |
- |
|
| ALQA |
Alliqua BioMedical Inc |
Director |
– • – |
2014-09-03 |
4 |
OE |
$4.24 |
$99,640 |
D/D |
23,500 |
272,750 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
